|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
Cisplatin is a chemotherapy drug used to treat cancer of the testicles, bladder, lung, stomach, esophagus, and ovaries, as well as other forms of cancer. Cisplatin can cause numerous side effects, including:
Some of the treatments mentioned below have been advocated for preventing or treating cisplatin side effects. For information on the use of natural treatments as a support to cancer chemotherapy in general, see the Cancer Treatment article.
Possible Harmful Interaction
The herb black cohosh is often used for menopausal symptoms. Because women receiving cancer chemotherapy may experience menopausal symptoms, black cohosh may appear a promising option. However, one test-tube study found that use of black cohosh may decrease the effectiveness of cisplatin.1
Possible Helpful Interaction
It has been suggested that many of the undesired effects of cisplatin are due to creation of free radicals, dangerous, naturally occurring substances that can damage many cells. For this reason, treatment with antioxidants has been proposed for preventing toxic side effects. However, as yet there is no more than minimal evidence for benefit.
One animal study tested a combination of substances with strong antioxidant properties ( vitamin E, Crocus sativus, and Nigella sativa) and found evidence that this mixture reduced the kidney toxicity of cisplatin.
A small human trial found evidence that use of vitamin E might help prevent nerve injury (peripheral neuropathy) caused by cisplatin, but because this was an open study, its results are not very reliable.7
Unfortunately, in open studies, the placebo effect and other confounding factors can play a significant role. (For more information on why this is the case, see Why Does This Database Rely on Double-blind Studies?)
In a better-designed, double-blind, placebo-controlled study of 48 people undergoing cancer treatment with cisplatin, participants were given either placebo or a combination of vitamin E, vitamin C, and selenium in hopes of reducing toxicity to the ears and kidneys.9 No significant benefits were seen.
Note that there are concerns that use of antioxidants could potential decrease the effectiveness of some forms of chemotherapy. For this reason, we strongly suggest that people on cancer chemotherapy do not use antioxidants, or any herbs or supplements, except in consultation with their physician.
References[ + ]
1. Rockwell S, Liu Y, Higgins S. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat. 2005;90:233–9.
2. Buckley JE, Clark VL, Meyer TJ, Pearlman NW. Hypomagnesemia after cisplatin combination chemotherapy. Arch Intern Med. 1984;144:2347.
3. Rodriguez M, Solanki DL, Whang R. Refractory potassium repletion due to cisplatin-induced magnesium depletion. Arch Intern Med. 1989;149:2592–4.
4. Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med. 1992;152:40–5.
5. van de Loosdrecht AA, Gietema JA, van der Graaf WT. Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemia. Acta Oncol. 2000;39:239–40.
6. Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer. 1999;35:1688–92.
7. Argyriou AA, Chroni E, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology. 2005;64:26–31.
8. Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol. 2004;93:320–7.
9. Weijl NI, Elsendoorn TJ, Lentjes EG, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer. 2004;40:1713–23.
10. Gaedeke J, Fels LM, Bokemeyer C, et al. Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant. 1996;11:55–62.
11. Scambia G, De Vincenzo R, Ranelletti FO, et al. Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur J Cancer. 1996;32A:877–82.
12. Manusirivithaya S, Sripramote M, Tangjitgamol S, et al. Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin. Int J Gynecol Cancer. 2004;14:1063–9.
13. Maestri A, De Pasquale Ceratti A, Cundari S, et al. A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy. Tumori. 2005;91:135–8.
Last reviewed December 2015 by EBSCO CAM Review Board
Last Updated: 12/15/2015
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.